Clinical trial
Ultrasound-Guided Lumbar Erector Spinae Plane Block Versus Transversus Abdominis Plane Block for Postoperative Analgesia in Children Undergoing Open Inguinal Hernia Repair: A Randomized Double-Blind Controlled Trial
NCT07916233 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasound-Guided Lumbar Erector Spinae Plane Block Versus Transversus Abdominis Plane Block for Postoperative Analgesia in Children Undergoing Open Inguinal Hernia Repair: A Randomized Double-Blind Controlled Trial
- Lead sponsor
- Beni-Suef University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- May 31, 2027
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inguinal hernia, postoperative pain
Arms
As registered; 2 arms.
-
Group E: Lumbar Erector Spinae Plane Block (ESPB)
Children in Group E receive an ultrasound-guided lumbar erector spinae plane block (ESPB) performed in the lateral decubitus position prior to surgical incision following general anesthesia induction. A 22-gauge 50-mm echogenic needle is advanced in-plane to contact the L1 transverse process deep to the erector spinae muscle. After negative aspiration and hydrodissection verification with 1-2 mL saline, bupivacaine 0.25% at a volume of 0.5 mL/kg (maximum 20 mL; total dose 1.25 mg/kg) is injected incrementally. Identical sterile dressings are applied over both the paraspinal and abdominal block sites to maintain blinding.
-
Group T: Transversus Abdominis Plane (TAP) Block
Children in Group T receive an ultrasound-guided transversus abdominis plane (TAP) block performed in the supine position prior to surgical incision following general anesthesia induction. A 22-gauge 50-mm echogenic needle is advanced in-plane into the fascial plane between the internal oblique and transversus abdominis muscles at the mid-axillary line. After negative aspiration and hydrodissection verification with 1-2 mL saline, bupivacaine 0.25% at a volume of 0.5 mL/kg (maximum 20 mL; total dose 1.25 mg/kg) is injected incrementally. Identical sterile dressings are applied over both the paraspinal and abdominal block sites to maintain blinding.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Time to First Postoperative Rescue Analgesia Request
Measured as the duration (in hours) from the end of general anesthesia (tracheal extubation) until the first administration of rescue opioid. Rescue analgesia is triggered when a trained blinded observer records a Face, Legs, Activity, Cry, Consolability (FLACC) behavioral pain score greater than 3 on two consecutive assessments separated by 15 minutes.
Lead sponsor's other trials
Beni-Suef University, most recent start first.
+343 more trials See the organization page
Similar trials
Same condition (Hernia, Inguinal) and phase, most recent start first.
+276 more trials See the condition page